NKGen Biotech, Inc. (NKGN)
0.011
0.00 (0.00%)
USD |
OTCM |
Nov 06, 16:00
NKGen Biotech Total Assets (Quarterly)
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2025 | 16.02M |
| December 31, 2024 | 16.41M |
| September 30, 2024 | 15.25M |
| June 30, 2024 | 26.35M |
| March 31, 2024 | 26.70M |
| December 31, 2023 | 34.77M |
| September 30, 2023 | 58.11M |
| June 30, 2023 | 63.61M |
| March 31, 2023 | 175.68M |
| Date | Value |
|---|---|
| December 31, 2022 | 16.33M |
| September 30, 2022 | 173.88M |
| June 30, 2022 | 173.64M |
| March 31, 2022 | 173.80M |
| December 31, 2021 | 174.19M |
| September 30, 2021 | 174.48M |
| June 30, 2021 | 174.74M |
| March 31, 2021 | 0.2795M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 902.56M |
| C4 Therapeutics, Inc. | 331.80M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |